| CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice Y Chen, RR Ramjiawan, T Reiberger, MR Ng, T Hato, Y Huang, H Ochiai, ... Hepatology 61 (5), 1591-1602, 2015 | 420 | 2015 |
| Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics PH Reddy, R Tripathi, Q Troung, K Tirumala, TP Reddy, V Anekonda, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (5), 639-649, 2012 | 404 | 2012 |
| Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases PH Reddy, TP Reddy, M Manczak, MJ Calkins, U Shirendeb, P Mao Brain research reviews 67 (1-2), 103-118, 2011 | 381 | 2011 |
| Mitochondria as a therapeutic target for aging and neurodegenerative diseases P H Reddy, T P Reddy Current Alzheimer Research 8 (4), 393-409, 2011 | 250 | 2011 |
| Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and … P Mao, M Manczak, MJ Calkins, Q Truong, TP Reddy, AP Reddy, ... Human Molecular Genetics 21 (13), 2973-2990, 2012 | 179 | 2012 |
| A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations TP Reddy, RR Rosato, X Li, S Moulder, H Piwnica-Worms, JC Chang Breast Cancer Research 22, 1-11, 2020 | 122 | 2020 |
| Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31 TP Reddy, M Manczak, MJ Calkins, P Mao, AP Reddy, U Shirendeb, ... International journal of environmental research and public health 8 (1), 203-221, 2011 | 54 | 2011 |
| Oestradiol and diet modulate energy homeostasis and hypothalamic neurogenesis in the adult female mouse EP Bless, T Reddy, KD Acharya, BS Beltz, MJ Tetel Journal of neuroendocrinology 26 (11), 805-816, 2014 | 44 | 2014 |
| Utility of Cell-Free DNA Detection in Transplant Oncology T Reddy, A Esmail, JC Chang, RM Ghobrial, M Abdelrahim Cancers 14 (3), 743, 2022 | 16 | 2022 |
| Targeting nitric oxide: say NO to metastasis TP Reddy, SA Glynn, TR Billiar, DA Wink, JC Chang Clinical Cancer Research 29 (10), 1855-1868, 2023 | 15 | 2023 |
| Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs TP Reddy, DS Choi, AC Anselme, W Qian, W Chen, J Lantto, ID Horak, ... Breast Cancer Research 22, 1-12, 2020 | 13 | 2020 |
| Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review TP Reddy, U Khan, EA Burns, M Abdelrahim World Journal of Clinical Oncology 11 (11), 959, 2020 | 6 | 2020 |
| Metastatic triple‐negative breast cancer: Established and emerging treatments A Puri, TP Reddy, TA Patel, JC Chang The Breast Journal 26 (9), 1793-1796, 2020 | 6 | 2020 |
| Procedure-Economical, Enantioselective Total Syntheses of Polycyclic Natural Products and Analogues Containing a 3a-Hydroxyhexahydropyrrolo [2, 3-b] indole-2-carboxylic Acid … PQ Huang Synlett 31 (17), 1681-1690, 2020 | 5 | 2020 |
| P0288: CXCR4 inhibition reverts immunosuppressive tumor microenvironment and facilitates Anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma T Reiberger, C Yunching, RR Ramjiawan, RR Ng, T Hato, Y Huang, ... Journal of Hepatology, S416, 2015 | 2 | 2015 |
| CXCR4 inhibition in combination with anti-PD1 immunotherapy results in an effective immune response during treatment with sorafenib in hepatocellular carcinoma: 920 T Reiberger, RR Ramjiawan, Y Chen, MR Ng, T Hato, EC Unan, ... Hepatology 60, 644A, 2014 | 2 | 2014 |
| Chromosomal alterations of pediatric malignancy in a West Texas population A Rajan, S Tonk, C Bose, S Singh, S Swarup, T Reddy, S Chavali, ... The Southwest Respiratory and Critical Care Chronicles 8 (33), 7-28, 2020 | 1 | 2020 |
| CXCR4 inhibition facilitates anti-PD-1 immunotherapy by reprogramming the tumor microenvironment during sorafenib treatment in hepatocellular carcinoma Y Chen, T Reiberger, R Ramjiawan, MR Ng, T Hato, EC Unan, TP Reddy, ... Cancer Immunology Research 3 (10), 2015 | 1 | 2015 |
| Leukosome-based siRNA strategy for targeting ribosomal protein L39 (RPL39) in metaplastic breast cancer MF Chervo, C Mancino, F Giordano, TP Reddy, W Qian, J Zhou, ... Cancer Research 83 (7_Supplement), 2709-2709, 2023 | | 2023 |
| NOS inhibition reverses epithelial-to-mesenchymal transition and synergizes with alpelisib in metaplastic breast cancer TP Reddy, A Puri, L Guzman-Rojas, C Thomas, W Qian, J Zhou, H Zhao, ... Cancer Research 83 (7_Supplement), 3447-3447, 2023 | | 2023 |
P. Hemachandra ReddyTexas Tech Health Sciences CenterVerified email at ttuhsc.edu
